Sort   by:  
 Page size 
TranscriptomicsscRNA-seq of embryonic skin development (developmental time series in full-thickness dorsal skin of mouse embryos)
In this study, we analysed early embryonic skin development (mus musculus; C57BL/6J) at the transcriptional level. Major questions concerned the cell type composition of early embryonic skin, and the emergence of transcriptional heterogeneity among epithelial and stromal precursor cells. Cells were ...
ORGANISM(S): Mus musculus 
2023-07-16 | E-MTAB-11920 | biostudies-arrayexpress
ProteomicsThe citrullinating enzyme PADI4 governs progenitor cell proliferation and translation in developing hair follicles
Posttranslational protein modifications have emerged as a mechanism regulating progenitor cell state transitions during tissue formation. Herein, we exploit the stereotyped hair follicle development to delineate the function of PADI4; an enzyme converting peptidylarginine to citrulline. Single cell-...
ORGANISM(S): Mus musculus (Mouse) 
2025-07-28 | PXD064137 | Pride
Mouse Hair follicle Citrullination Padi4 
UnknownCorrelation of Immunological and Molecular Profiles with Response to Crizotinib in Alveolar Soft Part Sarcoma: An Exploratory Study Related to the EORTC 90101 "CREATE" Trial.
Not available
S-EPMC9145625 | biostudies-literature
UnknownPanitumumab plus 5-fluorouracil and folinic acid or 5-fluorouracil and folinic acid alone as maintenance therapy in RAS wild-type metastatic colorectal cancer (PanaMa, AIO KRK 0212): final efficacy analysis of a randomised, open-label, phase 2 trial.
Not available
S-EPMC11719858 | biostudies-literature
UnknownPanitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212).
Not available
S-EPMC8683209 | biostudies-literature
UnknownDermatology-related quality-of-life outcomes in patients with RAS wild-type metastatic colorectal cancer treated with fluorouracil and folinic acid with or without panitumumab (Pmab) maintenance after FOLFOX + Pmab induction: a prespecified secondary analysis of the phase II randomized PanaMa (AIO KRK 0212) trial.
Not available
S-EPMC11452331 | biostudies-literature
UnknownIncorporating the Patient Voice in Sarcoma Research: How Can We Assess Health-Related Quality of Life in This Heterogeneous Group of Patients? A Study Protocol.
Not available
S-EPMC7792589 | biostudies-literature
UnknownSinonasal Sarcomas Management: An International Consensus Statement.
Not available
S-EPMC12761347 | biostudies-literature
GenomicsMetabolic effects of chronic dihydronicotinamide riboside (NRH) administration in mice - Microbiome 16S rRNA sequencing of murine feces (NRH treatment)
NAD+ is a crucial cofactor for the activity of various enzymes, including sirtuins and ADP-ribosyl transferases, and its decline is associated with aging and metabolic-related diseases. Therefore, a strong interest has been raised in the therapeutic use of NAD+ precursors (Vitamin B3s), but many suf...
ORGANISM(S): Mus musculus 
2026-03-09 | E-MTAB-14177 | biostudies-arrayexpress
UnknownUltra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities.
Not available
S-EPMC8319065 | biostudies-literature
Sort   by:  
 Page size